Published date: 3 July 2020

Awarded contract - This means that the contract has been awarded to a supplier.


Closing: 29 May 2020

Contract summary

Industry

  • Pharmaceutical products - 33600000

Location of contract

Any region, Scotland, Wales, Northern Ireland, Isle of Man, Channel Islands

Value of contract

£5,680,769.73

Procurement reference

tender_240212/867245

Published date

3 July 2020

Closing date

29 May 2020

Contract start date

17 June 2020

Contract end date

31 January 2021

Contract type

Supply contract

Procedure type

Open procedure (above threshold)

Any interested supplier may submit a tender in response to an opportunity notice.

This procedure can be used for procurements above the relevant contract value threshold.

This is an accelerated procedure.

Justification

The covid-19 outbreak has given rise to an urgent need for the supply of: Lopinavir/ritonavir - tablets or oral solution; Hydroxychloroquine - tablets; Dexamethasone - oral solution or tablets; and Azithromycin -capsules, tablets or oral solution because the authority needs to be in a position to treat the population as required. This does not give the authority sufficient time to comply with the standard open procedure timescales for this procurement. The authority considers this to be a state of urgency which it has duly substantiated. Accordingly, the authority is using the accelerated time limits permitted under the Public Contract Regulations 2015 (Regulation 27(5) for the open procedure) in respect of this procurement.

Contract is suitable for SMEs?

Yes

Contract is suitable for VCSEs?

No

Description

Procurement exercise for a contract for the supply of stockpiled medicines to include: lopinavir/ritonavir- tablets or oral solution; hydroxychloroquine - tablets; dexamethasone - oral solution or tablets and azithromycin - capsules, tablets or oral solution. Deliveries will be required over an initial period between 15th June and 30 September 2020 with an option to extend for up to an additional 4 months.
Details of awarded suppliers, noting that due to policy reasons the contracting authority were unable to proceed to award suppliers for hydroxychloroquine.

More information

Attachments

Award information

Awarded date

17 June 2020

Contract start date

17 June 2020

Contract end date

31 January 2021

Total value of contract

£5,680,769.73

This contract was awarded to 7 suppliers.

AbbVie Ltd

Address

AbbVie House, Vanwall Road, Vanwall Business Park, Maidenhead, Berks, SL6 4UB

Reference

Companies House number: 08004972

Supplier is SME?

No

Supplier is VCSE?

No

Mercury Pharmaceuticals Ltd

Address

Capital House, 1st Floor, 85 King William Street, London, EC4N 7BL

Reference

Companies House number: 02330913

Supplier is SME?

No

Supplier is VCSE?

No

Pfizer Ltd

Address

Walton Oaks, Dorking Road, Tadworth, KT20 7NS

Reference

Companies House number: 00526209

Supplier is SME?

No

Supplier is VCSE?

No

HFA Healthcare Products Ltd

Address

Studios 13, 15, 22 and 24, 50-54 St Paul's Square, West Midlands, Birmingham, B3 1QS

Reference

Companies House number: 09208084

Supplier is SME?

Yes

Supplier is VCSE?

No

SA2 Ltd

Address

23 Middleton Park Circus, Leeds, LS10 4LX

Reference

Companies House number: 07402228

Supplier is SME?

Yes

Supplier is VCSE?

No

Accord-UK Ltd

Address

Whiddon Valley, Barnstaple, Devon, EX32 8NS

Reference

Companies House number: 00079585

Supplier is SME?

No

Supplier is VCSE?

No

Firstline Pharma Ltd

Address

Ravalco House, Cleveland Way, Hemel Hempstead Industrial Estate, Hemel Hempstead, HP2 7DL

Reference

Companies House number: 08065603

Supplier is SME?

Yes

Supplier is VCSE?

No

About the buyer

Address

2nd Floor, Rutland House
Runcorn
WA7 2ES
England

Email

Lynne.Nichols@dhsc.gov.uk